Literature DB >> 36228997

Strides Toward a Better Understanding of the "Current Efforts and Challenges Facing Responses to Monkeypox in United Kingdom".

ArunSundar MohanaSundaram1, Thukani Sathanantham Shanmugarajan2, Ravichandiran Velayutham3.   

Abstract

Entities:  

Year:  2022        PMID: 36228997      PMCID: PMC9550296          DOI: 10.1016/j.bj.2022.10.002

Source DB:  PubMed          Journal:  Biomed J        ISSN: 2319-4170            Impact factor:   7.892


× No keyword cloud information.
Letter to the Editor We read the article by Idris and Adesola [1] about the current efforts in the prevention and control of Monkeypox and the challenges encountered during the outbreak in the United Kingdom with great interest. We would like to raise some concerns and foster a deeper understanding of the topic that requires discussion. Globally, the United Kingdom is one of the ten most affected countries due to Monkeypox with about 3635 confirmed cases as of 26 September 2022 [2]. In the epidemiological milieu, the authors have indicated that the termination of vaccination against smallpox is the reason underpinning the resurgence in human Monkeypox cases, but they didn't emphasize that waning smallpox immunity in the general population plays a pivotal role. In this line, a recent report by Nguyen et al. found that the individual immunity to Monkeypox declines at a rate of 1.29% per year until it reaches zero percentage, whereupon the individual becomes vulnerable to Monkeypox [3]. In addition to the clinical symptoms specified by the authors (based on previous outbreaks), a recent observational analysis of the UK population showed that clinicians should be aware of the unusually increased cases presenting genital and perianal skin lesions [4]. The authors have not mentioned the risk of Monkeypox infection in the vulnerable populations (except the children)—particularly pregnant women [5] and immunocompromised persons. There was no mentioning of vertical transmission of the virus from the mother to the fetus and sexual transmission. In addition to ramping up the conventional surveillance approaches in health care and community settings, the authors have not discussed the utility of wastewater-based surveillance as a component of disease surveillance toolbox. Overall, the communication is appealing but lacks certain critical information about Monkeypox in the epidemiological, clinical, and surveillance milieu.

Conflict of interest

The authors declare no conflicts of interest.
  4 in total

Review 1.  Reemergence of Human Monkeypox and Declining Population Immunity in the Context of Urbanization, Nigeria, 2017-2020.

Authors:  Phi-Yen Nguyen; Whenayon Simeon Ajisegiri; Valentina Costantino; Abrar A Chughtai; C Raina MacIntyre
Journal:  Emerg Infect Dis       Date:  2021-04       Impact factor: 6.883

Review 2.  Monkeypox: disease epidemiology, host immunity and clinical interventions.

Authors:  Fok-Moon Lum; Anthony Torres-Ruesta; Matthew Z Tay; Raymond T P Lin; David C Lye; Laurent Rénia; Lisa F P Ng
Journal:  Nat Rev Immunol       Date:  2022-09-05       Impact factor: 108.555

Review 3.  Demographic and clinical characteristics of confirmed human monkeypox virus cases in individuals attending a sexual health centre in London, UK: an observational analysis.

Authors:  Nicolò Girometti; Ruth Byrne; Margherita Bracchi; Joseph Heskin; Alan McOwan; Victoria Tittle; Keerti Gedela; Christopher Scott; Sheel Patel; Jesal Gohil; Diarmuid Nugent; Tara Suchak; Molly Dickinson; Margaret Feeney; Borja Mora-Peris; Katrina Stegmann; Komal Plaha; Gary Davies; Luke S P Moore; Nabeela Mughal; David Asboe; Marta Boffito; Rachael Jones; Gary Whitlock
Journal:  Lancet Infect Dis       Date:  2022-07-01       Impact factor: 71.421

4.  Current efforts and challenges facing responses to Monkeypox in United Kingdom.

Authors:  Ibrahim Idris; Ridwan Olamilekan Adesola
Journal:  Biomed J       Date:  2022-08-05       Impact factor: 7.892

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.